Controlled substances became a little less controlled during the pandemic. That benefited both patients (for their health) and telehealth startups (to make money).
Although telemedicine surged during the pandemic, patients relying on behavioral health medications worry that without action to extend the loosened rules, it'll be harder to get their meds.